| Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer (NCT05084677) | Tianjin Medical University Cancer Institute and Hospital | 2021-01-01 |
| Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL) (NCT04704063) | Yuen Kah Hay | 2021-01-01 |
| To Evaluate the Efficacy and Safety of Anlotinib Combined With Furmonertinib Mesylate in Lung Cancer (NCT04671303) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-01-01 |
| Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure (NCT05463367) | Northwestern University | 2021-01-01 |
| Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma (NCT05232552) | Zhejiang Cancer Hospital | 2021-01-01 |
| Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection (NCT04443868) | Sanotize Research and Development corp. | 2021-01-01 |
| Arsenic Trioxide for Structural p53 Mutations (NCT04695223) | Shanghai Changzheng Hospital | 2021-01-01 |
| Control of Pain Due to Dentin Hypersensitivity in Individuals With Molar-incisor Hypomineralization (NCT04407702) | University of Nove de Julho | 2021-01-01 |
| Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis (NCT04677192) | Fudan University | 2021-01-01 |
| Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma (NCT04065152) | Assistance Publique - Hôpitaux de Paris | 2021-01-01 |
| The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer (NCT04992026) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2021-01-01 |
| Use of a Treated, Devitalized and Sterile Meniscus Segment (MENISC-T) in the Treatment of Scaphotrapeziotrapezoid Osteoarthritis (NCT05250726) | TBF Genie Tissulaire | 2021-01-01 |
| Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone (NCT04827537) | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 2021-01-01 |
| Cardiac Index and General Anesthesia Without Opioid. (NCT05446623) | Centre Hospitalier de Montauban | 2021-01-01 |
| A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION (NCT04262375) | University Health Network, Toronto | 2021-01-01 |
| Placental Transfusion Effect on Hemodynamics of Premature Newborns (NCT04811872) | Marwa Mohamed Farag | 2021-01-01 |
| Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC (NCT05171309) | Nanfang Hospital, Southern Medical University | 2021-01-01 |
| Blinatumomab Bridging Therapy for BALL (NCT04556084) | Michael Burke | 2021-01-01 |
| Quantitation of Bacteria Associated With Severe Periodontitis by Real -Time PCR Following Application of Diode Laser (NCT05222737) | Alexandria University | 2021-01-01 |
| ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma" (NCT04684667) | Assiut University | 2021-01-01 |
| Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study (NCT04334993) | Israeli Medical Association | 2021-01-01 |
| Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes (NCT06390748) | Lin Chen | 2021-01-01 |
| FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy (NCT04491084) | Albert Einstein College of Medicine | 2021-01-01 |
| Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks (NCT04253132) | NeuroTau, Inc. | 2021-01-01 |
| Comparison Between Dexmeditomidine, Midazolam and Ketamine as a Sedative to Help Cannula Insertion in Pediatric Patient (NCT04704622) | Ain Shams University | 2021-01-01 |
| Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Knee Replacement in Patients With High PCS Scores (NCT03797612) | Adynxx, Inc. | 2021-01-01 |
| Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1) (NCT04589208) | New York State Psychiatric Institute | 2021-01-01 |
| Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions. (NCT04688736) | Institute of Hematology & Blood Diseases Hospital, China | 2021-01-01 |
| Niraparib Combined With Radiotherapy in rGBM (NCT04715620) | Tianjin Huanhu Hospital | 2021-01-01 |
| A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH) (NCT02528708) | Yale University | 2021-01-01 |
| Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer (NCT04641728) | Saitama Medical University International Medical Center | 2021-01-01 |
| Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Mastectomy in Patients With High PCS Scores (NCT04104919) | Adynxx, Inc. | 2021-01-01 |
| Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors (NCT04803318) | Second Affiliated Hospital of Guangzhou Medical University | 2021-01-01 |
| Safety of HMA-CD20 in Patients With HFrEF (NCT03332888) | Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud | 2021-01-01 |
| Groningen International Study on Sentinel Nodes in Vulvar Cancer-III (NCT05076942) | University Medical Center Groningen | 2021-01-01 |
| Beta-Tricalcium Phosphate and Concentrated Growth Factors in Treatment of Intra-bony Defect Randomized Clinical Trial (NCT04698317) | Tanta University | 2021-01-01 |
| Carbon Nanoparticles vs Indocyanine Green (NCT04759820) | LI XIN-XIANG | 2021-01-01 |
| Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat (NCT04712942) | University of Leipzig | 2021-01-01 |
| Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer. (NCT04720131) | Beijing Friendship Hospital | 2021-01-01 |
| Efficacy of Roflumilast in the Treatment of Psoriasis (NCT04549870) | Bispebjerg Hospital | 2021-01-01 |
| HAIC+Lenvatinib+Tislelizumab vs D-TACE+Lenvatinib+Tislelizumab for Unresectable HCC (NCT05582278) | Wen Li | 2021-01-01 |
| Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML. (NCT04904237) | Shanghai Jiao Tong University School of Medicine | 2021-01-01 |
| Effect of Continous Intravenous Lidocaine Infusion Intraoperative for Craniotomy Tumor Removal Surgery (NCT04773093) | Indonesia University | 2021-01-01 |
| Oral Arsenic Trioxide for NPM1-mutated AML (NCT04689815) | The University of Hong Kong | 2021-01-01 |
| Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts (NCT05023408) | Jinnah Postgraduate Medical Centre | 2021-01-01 |
| Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer (NCT04947280) | Fudan University | 2021-01-01 |
| Reduction or Discontinuation of TNF-α Inhibitor in Non-infectious Uveitis Patients (NCT05155592) | Dan Liang | 2021-01-01 |
| Lovastatin for Treatment of Brain Arteriovenous Malformations (NCT04297033) | Beijing Tiantan Hospital | 2021-01-01 |
| Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty (NCT05324995) | Isfahan University of Medical Sciences | 2021-01-01 |
| Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis. (NCT04072874) | Universidad de Antioquia | 2021-01-01 |
| Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis (NCT04523402) | Eastern Hepatobiliary Surgery Hospital | 2020-12-31 |
| ATG Individualized Dosing Model in URD-PBSCT. (NCT06572462) | Chinese PLA General Hospital | 2020-12-31 |
| A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer (NCT04620330) | Verastem, Inc. | 2020-12-31 |
| A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT) (NCT04600817) | TJ Biopharma Co., Ltd. | 2020-12-31 |
| Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (NCT04484012) | City of Hope Medical Center | 2020-12-31 |
| Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) (NCT04385277) | Children's Oncology Group | 2020-12-31 |
| Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) (NCT04614337) | Lumos Pharma | 2020-12-31 |
| Almonertinib Combined With Pyrotinib in the Treatment of Advanced NSCLC Patients With HER-2 Amplification/Mutation After EGFR-TKI Resistance (NCT04785729) | Sun Yat-sen University | 2020-12-31 |
| GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19) (NCT04673149) | GeneOne Life Science, Inc. | 2020-12-31 |
| Almonertinib for Advanced NSCLC Patients With Rare Mutations in EGFR (NCT04785742) | Sun Yat-sen University | 2020-12-31 |
| Eltrombopag for Chemotherapy-induced Thrombocytopenia (NCT04600960) | Institute of Hematology & Blood Diseases Hospital, China | 2020-12-31 |
| BO-112 With Pembrolizumab in Unresectable Malignant Melanoma (NCT04570332) | Highlight Therapeutics | 2020-12-30 |
| Study of LP002 for the Treatment of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (NCT04600947) | Taizhou HoudeAoke Biomedical Co., Ltd. | 2020-12-30 |
| RAPA-501-Allo Therapy of COVID-19-ARDS (NCT04482699) | Rapa Therapeutics LLC | 2020-12-30 |
| Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma (NCT04622566) | Peking University Cancer Hospital & Institute | 2020-12-30 |
| A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma (NCT04379167) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2020-12-30 |
| KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers (NCT04473690) | KBio Inc | 2020-12-30 |
| A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (NCT04695652) | Medigen Vaccine Biologics Corp. | 2020-12-30 |
| Comparison of Fluorescein-INtra-VItal Microscopy Versus Conventional Frozen Section Diagnosis for intraOperative Histopathological Evaluation (NCT04597801) | Technical University of Munich | 2020-12-30 |
| Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer (NCT04373031) | Providence Health & Services | 2020-12-30 |
| CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT04493164) | M.D. Anderson Cancer Center | 2020-12-30 |
| Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy (NCT04554680) | National University Hospital, Singapore | 2020-12-30 |
| Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis (NCT04717310) | Reistone Biopharma Company Limited | 2020-12-30 |
| Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients (NCT04686916) | Initiator Pharma | 2020-12-30 |
| Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management. (NCT04441762) | Oman Medical Speciality Board | 2020-12-30 |
| Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults (NCT04715997) | Genexine, Inc. | 2020-12-30 |
| A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease (NCT04658186) | UCB Biopharma SRL | 2020-12-30 |
| A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations (NCT04639219) | AstraZeneca | 2020-12-30 |
| Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD (NCT04704921) | AbbVie | 2020-12-29 |
| Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer (NCT04592237) | M.D. Anderson Cancer Center | 2020-12-29 |
| Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine (NCT04690335) | Meissa Vaccines, Inc. | 2020-12-29 |
| A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis (NCT04744207) | Gesynta Pharma AB | 2020-12-29 |
| Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection (NCT04350138) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-12-29 |
| Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers (NCT04666012) | Cellid Co., Ltd. | 2020-12-29 |
| MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab (NCT04554836) | TheraOp | 2020-12-29 |
| A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19 (NCT04627584) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2020-12-29 |
| IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) (NCT04524949) | Imcyse SA | 2020-12-29 |
| Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy (NCT04715360) | Hayandra Peduli Foundation | 2020-12-29 |
| Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer (NCT04596150) | CytomX Therapeutics | 2020-12-29 |
| CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD. (NCT04639362) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2020-12-29 |
| Evolutionary Therapy for Rhabdomyosarcoma (NCT04388839) | H. Lee Moffitt Cancer Center and Research Institute | 2020-12-29 |
| A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration (NCT04684394) | Gemini Therapeutics, Inc. | 2020-12-29 |
| Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy (NCT04645004) | Thomas Jefferson University | 2020-12-29 |
| A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS (NCT04623996) | Sumitomo Pharma America, Inc. | 2020-12-28 |
| Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC) (NCT04574817) | Taizhou Hanzhong biomedical co. LTD | 2020-12-28 |
| Magnesium for Peroral Endoscopic Myotomy (NCT04638881) | Stanford University | 2020-12-28 |
| Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities (NCT04751409) | M.D. Anderson Cancer Center | 2020-12-28 |
| Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer (NCT04731740) | Saint Petersburg State University, Russia | 2020-12-28 |
| Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma (NCT04669808) | Sirnaomics | 2020-12-28 |
| A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer (NCT04538742) | AstraZeneca | 2020-12-28 |